GRGDNP
Cat.No:CLP0032 Solarbio
CAS:114681-65-1
Molecular Formula:C23H38N10O10
Molecular Weight:614.62
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
{{cart_num}}
My CartCAS:114681-65-1
Molecular Formula:C23H38N10O10
Molecular Weight:614.62
Purity:≥95%
Appearance:Lyophilized powder
Storage:Store at -20℃,2 years.(Avoid freeze/thaw cycles)
Qty:
Size:
Product Type | Peptides |
CAS | 114681-65-1 |
Sequence(1LC) | GRGDNP |
Sequence(3LC) | Gly-Arg-Gly-Asp-Asn-Pro |
Molecular Formula | C23H38N10O10 |
Molecular Weight | 614.62 |
Purity | ≥95% |
Appearance | Lyophilized powder |
Solubility | H2O:≥50 mg/mL; DMSO:≥50 mg/mL; *Ultrasonic solubilization; |
Salt Form | Trifluoroacetate salt |
Source | Synthetic |
Storage | Store at -20℃,2 years.(Avoid freeze/thaw cycles) |
Category/Label | RGD,RAD Peptides |
Background | RGD peptide (GRGDNP) is an inhibitor of integrin-ligand interactions. RGD peptide (GRGDNP) competitively inhibits α5β1 binding with extracellular matrice (ECM). RGD peptide (GRGDNP) promotes apoptosis through activation of conformation changes that enhance pro-caspase-3 activation and autoprocessing. RGD peptide (GRGDNP) plays an important role in cell adhesion, migration, growth, and differentiation. |
Reference | [1] Mogford, J. et al. J. Clin. Invest. 100, 1647 (1997); [2] Sasamoto, A. et al. Am. J. Physiol. Cell. Physiol. 288, C1012 (2005); [3] Sarin, V. et al. J. Physiol. 564, 603 (2005). |
Unit | Bottle |
Specification | 1mg 5mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.